| Schedule of the Reconciliation of the Basic and Diluted Weighted Average Number of Shares Outstanding |
The following table summarizes the reconciliation of the basic weighted average number of shares outstanding and the diluted weighted average number of shares outstanding: | | | | | | | | | | | | | | | | | Three months ended March 31, | | | | 2026 | | 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in US $ millions, except share and per share amounts) | | Numerator: | | | | | | | | | Net loss | (581) | | | (682) | | | | | | | | | | | | | | | Denominator: | | | | | | | | | Basic weighted average number of shares outstanding | 1,303,357,874 | | 1,295,377,376 | | | | | | Weighted average effect of dilutive securities: | | | | | | | | | Stock options | — | | — | | | | | | Restricted share units | — | | — | | | | | | | | | | | | | | Deferred share units | — | | — | | | | | | Diluted weighted average number of shares | 1,303,357,874 | | 1,295,377,376 | | | | | | | | | | | | | | Net loss per share: | | | | | | | | | Basic | $ | (0.45) | | | $ | (0.53) | | | | | | | Diluted | $ | (0.45) | | | $ | (0.53) | | | | | | | | | | | | | | | Common stock equivalents excluded from net loss per diluted share because they are anti-dilutive: | | | | | | | | | Stock options | 12,211,409 | | 14,767,620 | | | | | | | Restricted share units | 4,058,554 | | 5,300,232 | | | | | | Convertible senior notes(1) | — | | 6,388,480 | | | | | | | Deferred share units | 5,657 | | 15,488 | | | | | | | 16,275,620 | | 26,471,820 | | | | | |
(1) In the third quarter of 2020, the Company issued $920 million aggregate principal amount of 0.125% convertible senior notes. The convertible senior notes were settled in the fourth quarter of 2025 with no further dilutive effect on securities thereafter.
|